U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07411144) titled 'Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma' on Feb. 01.
Brief Summary: What is this study about?
This study looks at whether continuing chemotherapy with a drug called gemcitabine after initial treatment can help patients with diffuse pleural mesothelioma keep their cancer under control for a longer time.
Diffuse pleural mesothelioma is a rare and aggressive cancer that affects the lining of the lungs. Even after standard chemotherapy, the disease often comes back quickly. Doctors are therefore looking for maintenance treatments that may delay cancer progression.
What does this mean for patients and fam...